BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Ciprofibrate
,
rs2476601
,
PBX1
,
Coagulation
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tnfrsf11b protein human
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification and Association of Polymorphism rs2073618 of the <em>Osteoprotegerin </em>Gene in Typ…
Establishment of a TNFRSF11B knock-out human induced pluripotent stem cell line (KSCBi002-B-2) via C…
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rh…
Association of osteoporosis risk and polymorphisms of osteoprotegerin gene T950C in postmenopausal C…
Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian ra…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for tnfrsf11b protein human
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ